Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Nab-paclitaxel/Gemcitabine + SBRT in Pancreatic Cancer
NCT02723331Phase 2Completed
- Sponsor
- Academic Thoracic Oncology Medical Investigators Consortium
- Start
- Dec 2016
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by Academic Thoracic Oncology Medical Investigators Consortium. Started Dec 2016; status: completed.
02
Drugs
paclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02723331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723331.